Testing a simple blood test to find advanced liver scarring in primary care

This study is evaluating a new blood test called eLIFT that family doctors can use to screen for advanced liver scarring in patients with fatty liver disease or alcohol-related liver disease. The test uses simple measurements and easy calculations, making it practical for use in primary care settings. Researchers are comparing how well eLIFT performs against more specialized blood tests and imaging to see if it can reliably catch serious liver scarring before it progresses to cirrhosis.

Many patients with fatty liver disease or alcohol-related liver disease develop dangerous liver scarring without any obvious warning signs, and by the time they are diagnosed, the damage is often severe. Family doctors currently have few practical tools to identify these patients early, so this study aims to see whether eLIFT could help catch liver scarring sooner and guide patients to specialists before life-threatening complications develop.